It covers why GLP-1 drugs put muscle at risk, what the STEP trial data shows on lean mass changes, and why the scale alone cannot detect this problem.Read Part 1: Semaglutide & Muscle Loss Integrate InBody into your GLP-1 programme today Medical Disclaimer: This article is for informational and educational purposes only and is intended for healthcare professionals
DAILY LIFE: The product is indicated in cases of asthenia, muscle weakness
Yes, when administered under professional guidance, Lipotropic (MIC) + B12 injections are considered safe
At HerKare, treatment plans are tailored to individual goals and health history
The first and only GLP-1-based drug currently approved for weight loss, semaglutide (brand name Wegovy), has been available since 2021
These protective associations were weaker after adjusting for BMI (e.g., butter HR increased from 0.82 to 0.86), implying that body weight may play a mediating role